Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED)

Lahey Health

Status: Completed

Conditions: Diabetes Mellitus, Type 2

Treatments: Other: Pharmacist collaboration in diabetes care; Other: Usual care

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00541606

PAMPERED

Details and patient eligibility

About

The purpose of this study is to demonstrate that pharmacists working collaboratively with physicians and other providers in an ambulatory care setting can improve glucose, blood pressure, and lipid control, as well as improve quality of life, adherence to screening and general preventative measures.

Full description

It is evident that a multi-disciplinary approach is key to the success in controlling the disease of diabetes and its complications. The value of pharmacists' involvement in disease state management in producing positive outcomes for patients has been well documented in the literature. There have been several studies that have shown that pharmacists' involvement in diabetes care improves glycemic control. There are also studies that look at pharmacists' management of glycemic control and adherence to the ADA guidelines. Many of these studies are retrospective, lack a randomized control group, had a small study sample, or were short term. We undertook a prospective, randomized study to demonstrate that pharmacists working collaboratively with physicians and other providers in an ambulatory care setting can improve glucose, blood pressure, and lipid control, as well as improve quality of life, adherence to screening and general preventative measures.

Enrollment: 285 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients over the age of 18
• A1c > 8% within the 6 months prior to the data acquisition date
• Primary Care physician at Lahey Clinic Burlington site
• Diagnosis of T2 DM for minimum of 6 months

Exclusion criteria

• Concurrently enrolled in any other pharmacist-run or diabetes study
• Receiving diabetes management by an outside provider
• A medical condition that may adversely affect compliance with the treatment protocol

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

285 participants in 2 patient groups

Intervention

Experimental group

Description:

Received collaborative care including a clinical pharmacist practitioner.

Treatment:

Other: Pharmacist collaboration in diabetes care

Control

Active Comparator group

Description:

Patients received usual care directed by their physician.

Treatment:

Other: Usual care